Show simple item record

dc.contributor.authorMatsumoto, Yuri
dc.contributor.authorJasanoff, Alan Pradip
dc.date.accessioned2020-07-08T20:33:21Z
dc.date.available2020-07-08T20:33:21Z
dc.date.issued2013-01
dc.date.submitted2013-01
dc.identifier.issn0014-5793
dc.identifier.urihttps://hdl.handle.net/1721.1/126108
dc.description.abstractMetalloproteins have long been recognized as key determinants of endogenous contrast in magnetic resonance imaging (MRI) of biological subjects. More recently, both natural and engineered metalloproteins have been harnessed as biotechnological tools to probe gene expression, enzyme activity, and analyte concentrations by MRI. Metalloprotein MRI probes are paramagnetic and function by analogous mechanisms to conventional gadolinium or iron oxide-based MRI contrast agents. Compared with synthetic agents, metalloproteins typically offer worse sensitivity, but the possibilities of using protein engineering and targeted gene expression approaches in conjunction with metalloprotein contrast agents are powerful and sometimes definitive strengths. This review summarizes theoretical and practical aspects of metalloprotein-based contrast agents, and discusses progress in the exploitation of these proteins for molecular imaging applications.en_US
dc.description.sponsorshipNational Institutes of Health (Grant DP2‐OD002114)en_US
dc.description.sponsorshipNational Institutes of Health (Grant R01‐NS076462)en_US
dc.description.sponsorshipNational Institutes of Health (Grant R01‐NS076462)en_US
dc.description.sponsorshipDARPA (Grant W911NF‐10‐0059)en_US
dc.language.isoen
dc.publisherWileyen_US
dc.relation.isversionofhttp://dx.doi.org/10.1016/j.febslet.2013.01.044en_US
dc.rightsCreative Commons Attribution-NonCommercial-NoDerivs Licenseen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/en_US
dc.sourcePMCen_US
dc.titleMetalloprotein-based MRI probesen_US
dc.typeArticleen_US
dc.identifier.citationMatsumoto, Yuri and Alan Jasanoff. "Metalloprotein-based MRI probes." FEBS Letters 587, 8 (January 2013): 1021-1029 © 2013 Federation of European Biochemical Societiesen_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Brain and Cognitive Sciencesen_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Nuclear Science and Engineeringen_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Biological Engineeringen_US
dc.relation.journalFEBS Lettersen_US
dc.eprint.versionAuthor's final manuscripten_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dc.date.updated2020-03-11T15:14:50Z
dspace.date.submission2020-03-11T15:14:53Z
mit.journal.volume587en_US
mit.journal.issue8en_US
mit.licensePUBLISHER_CC
mit.metadata.statusComplete


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record